Genetic causes of primary immunodeficiency in the Jordanian population. [PDF]
Obeidat L +4 more
europepmc +1 more source
Abstract Background Pre‐surgical anxiety (PSA) and pre‐surgical fear (PSF) may hinder patient compliance, while patient satisfaction (PS) is vital for adherence to treatment recommendations. This prospective study investigated the impact of PSA and PSF, and the influence of patient demographics and postoperative pain, on PS after periodontal and ...
Anum Haider +4 more
wiley +1 more source
Evaluation of the effect of the COVID-19 pandemic on depression, anxiety and psychological resilience in patients with primary immunodeficiency. [PDF]
Muştucu A +4 more
europepmc +1 more source
Successfully performed video capsule endoscopy in an 8‐month‐old infant weighing 7.5 kg
Abstract Video capsule endoscopy (VCE) is a well‐established diagnostic tool for examining the small bowel. Limited data exist on its use in infants. To our knowledge, we present the first detailed case of a successful PillCam®SB3‐VCE performed in an 8‐month‐old infant weighing 7.5 kg with suspected small bowel bleeding following allogeneic ...
Paul‐Christoph Zeisler +3 more
wiley +1 more source
Primary Immunodeficiency: Specific antibody deficiency with normal IgG. [PDF]
Hatcher VR +3 more
europepmc +1 more source
Gut function among children treated for severe acute malnutrition: A cohort study in Uganda
Abstract Objectives Impaired gut function in children with severe acute malnutrition (SAM) is associated with morbidity. We aimed to assess changes in six biomarkers representing different domains of gut function among children with complicated SAM during nutritional rehabilitation, and to identify predictors of these changes.
Betty Lanyero +12 more
wiley +1 more source
Primary immunodeficiency as a cause of immune-mediated kidney diseases. [PDF]
Zhang C, Liang D, Liu Z.
europepmc +1 more source
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan +2 more
wiley +1 more source
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency. [PDF]
Lumry WR +12 more
europepmc +1 more source

